{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T20:08:01Z","timestamp":1794600481935,"version":"4.9.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jtos.2021.12.001","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T11:56:52Z","timestamp":1639396612000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":234,"special_numbering":"C","title":["Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-7542","authenticated-orcid":false,"given":"Namrata","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupesh","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1999-5661","authenticated-orcid":false,"given":"Anahita","family":"Kate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-939X","authenticated-orcid":false,"given":"Gunjan","family":"Saluja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prafulla K.","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2021.12.001_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00055735-200408000-00008","article-title":"Fungal keratitis","volume":"15","author":"Srinivasan","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.survophthal.2019.02.007","article-title":"Pharmacologic therapy of mycotic keratitis","volume":"64","author":"Sahay","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib3","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jtos.2021.12.001_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/09286589609080122","article-title":"Incidence of corneal ulceration in Madurai district, South India","volume":"3","author":"Gonzales","year":"1996","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.jtos.2021.12.001_bib5","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archopht.1993.01090120087027","article-title":"Incidence of ulcerative keratitis in a defined population from 1950 through 1988","volume":"111","author":"Erie","year":"1960","journal-title":"Arch Ophthalmol Chic Ill"},{"key":"10.1016\/j.jtos.2021.12.001_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/0301-4738.185592","article-title":"Recent advances in diagnosis and management of Mycotic Keratitis","volume":"64","author":"Maharana","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4103\/ijo.IJO_821_17","article-title":"Fungal keratitis: the Aravind experience","volume":"65","author":"Prajna","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ophtha.2005.10.063","article-title":"Risk factors for treatment outcome in fungal keratitis","volume":"113","author":"Lalitha","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.12.001_bib9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/myc.12822","article-title":"Fungal keratitis: an overview of clinical and laboratory aspects","volume":"61","author":"Mahmoudi","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.jtos.2021.12.001_bib10","doi-asserted-by":"crossref","first-page":"103802","DOI":"10.1016\/j.micpath.2019.103802","article-title":"Fungal keratitis: pathogenesis, diagnosis and prevention","volume":"138","author":"Niu","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jtos.2021.12.001_bib11","first-page":"315","article-title":"Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study","volume":"51","author":"Bharathi","year":"2003","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bjo.79.11.1024","article-title":"Causes of suppurative keratitis in Ghana","volume":"79","author":"Hagan","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib13","first-page":"377","article-title":"Aqueous pores created in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B","volume":"2","author":"Finkelstein","year":"1973","journal-title":"Membranes"},{"key":"10.1016\/j.jtos.2021.12.001_bib14","first-page":"210","article-title":"Mycotic keratitis: epidemiology, diagnosis and management","volume":"19","author":"Thomas","year":"2013","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jtos.2021.12.001_bib15","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.061562898","article-title":"Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors","volume":"98","author":"Podust","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2021.12.001_bib16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jtos.2021.12.001_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.1992.tb00001.x","article-title":"Terbinafine: mode of action and properties of the squalene epoxidase inhibition","volume":"126","author":"Ryder","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jtos.2021.12.001_bib18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/AAC.42.5.1057","article-title":"In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts","volume":"42","author":"Ryder","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jtos.2021.12.001_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1089\/jop.2016.0186","article-title":"Echinocandins in ocular therapeutics","volume":"33","author":"Patil","year":"2017","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2021.12.001_bib20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1345\/aph.1M237","article-title":"Echinocandins: the newest class of antifungals","volume":"43","author":"Sucher","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtos.2021.12.001_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/0301-4738.185592","article-title":"Recent advances in diagnosis and management of Mycotic Keratitis","volume":"64","author":"Maharana","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jamaophthalmol.2016.4096","article-title":"Effect of oral voriconazole on fungal keratitis in the mycotic ulcer treatment trial II (MUTT II): a randomized clinical trial","volume":"134","author":"Prajna","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib23","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/ICO.0000000000001365","article-title":"Comparison of oral voriconazole versus oral ketoconazole as an adjunct to topical natamycin in severe fungal keratitis: a randomized controlled trial","volume":"36","author":"Sharma","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.12.001_bib24","first-page":"597","article-title":"Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis","volume":"8","author":"Qiu","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib25","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1128\/JCM.00610-08","article-title":"In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder","volume":"46","author":"Lalitha","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jtos.2021.12.001_bib26","first-page":"672","article-title":"Comparison of natamycin and voriconazole for the treatment of fungal keratitis","volume":"128","author":"Prajna","year":"2010","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"10.1016\/j.jtos.2021.12.001_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","article-title":"The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole","volume":"131","author":"Prajna","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2006.07.033","article-title":"Topical and oral voriconazole in the treatment of fungal keratitis","volume":"143","author":"Bunya","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib29","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ophtha.2011.11.034","article-title":"Voriconazole for fungal corneal ulcers","volume":"119","author":"Parchand","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.12.001_bib30","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","article-title":"Activities of Caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi","volume":"41","author":"Diekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jtos.2021.12.001_bib31","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jtos.2021.12.001_bib32","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1128\/AAC.46.8.2546-2553.2002","article-title":"Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens","volume":"46","author":"Purkins","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jtos.2021.12.001_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2125.2003.01993.x","article-title":"Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety","volume":"56","author":"Purkins","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtos.2021.12.001_bib34","first-page":"1","article-title":"Infectious keratitis caused by rare and emerging micro-organisms","author":"Sahay","year":"2020","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2021.12.001_bib35","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1136\/bjo.2010.192815","article-title":"Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series","volume":"95","author":"Sharma","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib36","first-page":"657","article-title":"[Topical voriconazole as an effective treatment for fungal keratitis]","volume":"52","author":"Wang","year":"2016","journal-title":"Zhonghua Yan Ke Za Zhi Chin J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1590\/S0004-27492006000300028","article-title":"Use of oral voriconazole as adjunctive treatment of severe cornea fungal infection: case report","volume":"69","author":"Freda","year":"2006","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcrs.2007.09.031","article-title":"Use of voriconazole in fungal keratitis","volume":"34","author":"Jones","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jtos.2021.12.001_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.00762-06","article-title":"Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis","volume":"51","author":"Thiel","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jtos.2021.12.001_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/ICO.0000000000001781","article-title":"Management algorithm for fungal keratitis: the TST (topical, systemic, and targeted therapy) protocol","volume":"38","author":"Sharma","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.12.001_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226498","article-title":"Periocular contact dermatitis with use of topical voriconazole 1% in mycotic keratitis","volume":"2018","author":"Sahay","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jtos.2021.12.001_bib42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.survophthal.2019.02.007","article-title":"Pharmacologic therapy of mycotic keratitis","volume":"64","author":"Sahay","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/jop.2014.0004","article-title":"Safety and efficacy of intrastromal injection of 5% natamycin in experimental fusarium keratitis","volume":"30","author":"Mimouni","year":"2014","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2021.12.001_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajo.2008.02.023","article-title":"Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis","volume":"146","author":"Prakash","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2021.12.001_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/microorganisms6030058","article-title":"Phoma infections: classification, potential food sources, and their clinical impact","volume":"6","author":"Bennet","year":"2018","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/j.jtos.2021.12.001_bib46","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4103\/ijo.IJO_254_17","article-title":"Corneal ulcer due to a rare coelomycete fungus Chaetomium strumarium: case report and global review of Chaetomium keratomycosis","volume":"65","author":"Reddy","year":"2017","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2021.12.001_bib47","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.0.000055","article-title":"First report of Lasiodiplodia pseudotheobromae keratitis susceptible to voriconazole in an Indian mango grower","volume":"1","author":"Vanam","year":"2019","journal-title":"Access Microbiol"},{"key":"10.1016\/j.jtos.2021.12.001_bib48","doi-asserted-by":"crossref","DOI":"10.1099\/jmmcr.0.000091","article-title":"A rare case of fungal keratitis: diagnosis and management","volume":"2","author":"McElnea","year":"2015","journal-title":"JMM Case Rep"},{"key":"10.1016\/j.jtos.2021.12.001_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0181-5512(08)70332-2","article-title":"Usefulness of voriconazole in treatment of Phoma glomerate after penetrating injury","volume":"31","author":"Errera","year":"2008","journal-title":"J. Fr. Ophthalmol."},{"issue":"2","key":"10.1016\/j.jtos.2021.12.001_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00003226-200303000-00018","article-title":"Keratitis caused by an unusual fungus, Phoma species","volume":"22","author":"Rishi","year":"2003","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2021.12.001_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2054270415577760","article-title":"A case of Phoma fungal keratitis in a contact lens user","volume":"6","author":"Kumar","year":"2015","journal-title":"JRSM Open"},{"key":"10.1016\/j.jtos.2021.12.001_bib52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mmcr.2019.04.006","article-title":"Fungal keratitis caused by Didymella gardeniae (formerly Phoma gardeniae) successfully treated with topical voriconazole and miconazole","volume":"24","author":"Miyakubo","year":"2019","journal-title":"Med Mycol Case Rep"},{"issue":"3","key":"10.1016\/j.jtos.2021.12.001_bib53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11046-019-00335-w","article-title":"Fungal keratitis caused by colletotrichum dematium: case study and review","volume":"184","author":"Buchta","year":"2019","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.jtos.2021.12.001_bib54","first-page":"DD01","article-title":"Non traumatic keratitis due to colletotrichum coccodes: a case report","volume":"9","author":"Kotwal","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.jtos.2021.12.001_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaapos.2010.12.003","article-title":"Pediatric Metarrhizium anisopliae keratitis","volume":"15","author":"Motley","year":"2011","journal-title":"J. AAPOS"},{"issue":"3","key":"10.1016\/j.jtos.2021.12.001_bib56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/ICO.0b013e31815e9298","article-title":"Atypical fungal sclerokeratitis","volume":"27","author":"Amiel","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.12.001_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mmcr.2017.06.003","article-title":"Fungal keratitis caused by Metarhizium anisopliae complex","volume":"17","author":"Showail","year":"2017","journal-title":"Med Mycol Case Rep"},{"issue":"1","key":"10.1016\/j.jtos.2021.12.001_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12348-021-00255-1","article-title":"Fungal keratitis caused by Pseudallescheria boydii: clinical and mycological characteristics","volume":"11","author":"Izadi","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jtos.2021.12.001_bib59","first-page":"68","article-title":"Scedosporium apiospermum keratitis","volume":"20","author":"Sicilia","year":"2003","journal-title":"Rev Iberoam De Micol"},{"issue":"12","key":"10.1016\/j.jtos.2021.12.001_bib60","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/ICO.0000000000000969","article-title":"Scedosporium keratitis: an experience from a tertiary eye hospital in South India","volume":"35","author":"Rathi","year":"2016","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2021.12.001_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.joco.2017.08.004","article-title":"Fungal keratitis caused by rare organisms","volume":"30","author":"Tabatabaei","year":"2018","journal-title":"J Curr Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2021.12.001_bib62","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10384-007-0447-0","article-title":"Keratitis caused by a rare fungus, Malassezia restricta","volume":"51","author":"Suzuki","year":"2007","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2021.12.001_bib63","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4103\/ijo.IJO_836_16","article-title":"Corneal ulcer due to a rare pleosporalean member of the genus Bipolaris following cow tail injury to the eye: a case report and review of literature","volume":"65","author":"Pai","year":"2017","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2021.12.001_bib64","first-page":"389","article-title":"Rare fungal keratitis caused by Coprinellus Radians","volume":"185","author":"Lu","year":"2020","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jtos.2021.12.001_bib65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fmicb.2012.00120","article-title":"Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform","volume":"3","author":"Dai","year":"2012","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jtos.2021.12.001_bib66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajo.2014.04.007","article-title":"Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates","volume":"158","author":"Arboleda","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajo.2019.08.027","article-title":"Rose bengal photodynamic antimicrobial therapy for patients with progressive infectious keratitis: a pilot clinical study","volume":"208","author":"Naranjo","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib68","article-title":"Long-term outcomes of riboflavin photodynamic antimicrobial therapy as a treatment for infectious keratitis","volume":"15","author":"Martinez","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"10","key":"10.1016\/j.jtos.2021.12.001_bib69","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/ICO.0000000000001701","article-title":"Human corneal changes after rose bengal photodynamic antimicrobial therapy for treatment of fungal keratitis","volume":"37","author":"Martinez","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.12.001_bib70","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/eye.1991.68","article-title":"The role of penetrating keratoplasty in the management of microbial keratitis","volume":"5","author":"Kirkness","year":"1991","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2021.12.001_bib71","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1442-9071.2010.02473.x","article-title":"Voriconazole versus natamycin as primary treatment in fungal corneal ulcers","volume":"39","author":"Arora","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib72","first-page":"744","article-title":"Observation of therapeutical effect of natamycin in fungal corneal ulcer","volume":"10","author":"Wang","year":"2010","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib73","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ophtha.2012.09.023","article-title":"Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis","volume":"120","author":"Sharma","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.12.001_bib74","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/OPTH.S135112","article-title":"Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study","volume":"11","author":"Nada","year":"2017","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"10.1016\/j.jtos.2021.12.001_bib75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.ico.0000151539.92865.3e","article-title":"Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis","volume":"24","author":"Kalavathy","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.12.001_bib76","first-page":"257","article-title":"Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis","volume":"3","author":"Shao","year":"2010","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.12.001_bib77","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/09273948.2015.1057597","article-title":"Evaluation of intracameral amphotericin B in the management of fungal keratitis: randomized controlled trial","volume":"24","author":"Sharma","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jtos.2021.12.001_bib78","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/APO.0000000000000035","article-title":"Topical 5% natamycin with oral ketoconazole in filamentous fungal keratitis: a randomized controlled trial","volume":"4","author":"Rajaraman","year":"2015","journal-title":"Asia-Pac J Ophthalmol Phila Pa"},{"key":"10.1016\/j.jtos.2021.12.001_bib79","first-page":"173","article-title":"Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study","volume":"49","author":"Agarwal","year":"2001","journal-title":"Indian J Ophthalmol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:44:46Z","timestamp":1761540286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012421001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":79,"alternative-id":["S1542012421001403"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2021.12.001","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}